Open Access Data and Deep Learning for Cardiac Device Identification on Standard DICOM and Smartphone-based Chest Radiographs.

Journal: Radiology. Artificial intelligence
PMID:

Abstract

Purpose To develop and evaluate a publicly available deep learning model for segmenting and classifying cardiac implantable electronic devices (CIEDs) on Digital Imaging and Communications in Medicine (DICOM) and smartphone-based chest radiographs. Materials and Methods This institutional review board-approved retrospective study included patients with implantable pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac monitors who underwent chest radiography between January 2012 and January 2022. A U-Net model with a ResNet-50 backbone was created to classify CIEDs on DICOM and smartphone images. Using 2321 chest radiographs in 897 patients (median age, 76 years [range, 18-96 years]; 625 male, 272 female), CIEDs were categorized into four manufacturers, 27 models, and one "other" category. Five smartphones were used to acquire 11 072 images. Performance was reported using the Dice coefficient on the validation set for segmentation or balanced accuracy on the test set for manufacturer and model classification, respectively. Results The segmentation tool achieved a mean Dice coefficient of 0.936 (IQR: 0.890-0.958). The model had an accuracy of 94.36% (95% CI: 90.93%, 96.84%; 251 of 266) for CIED manufacturer classification and 84.21% (95% CI: 79.31%, 88.30%; 224 of 266) for CIED model classification. Conclusion The proposed deep learning model, trained on both traditional DICOM and smartphone images, showed high accuracy for segmentation and classification of CIEDs on chest radiographs. Conventional Radiography, Segmentation . © RSNA, 2024 See also the commentary by Júdice de Mattos Farina and Celi in this issue.

Authors

  • Felix Busch
    Institute for Diagnostic and Interventional Radiology, TUM School of Medicine and Health, TUM University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Keno K Bressem
    School of Medicine and Health, Institute for Cardiovascular Radiology and Nuclear Medicine, German Heart Center Munich, TUM University Hospital, Technical University of Munich, Munich, Germany.
  • Phillip Suwalski
    From the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).
  • Lena Hoffmann
    School of Medicine and Health, Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TUM University Hospital, Technical University of Munich, Munich, Germany.
  • Stefan M Niehues
    Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Denis Poddubnyy
    Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Marcus R Makowski
    School of Medicine and Health, Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TUM University Hospital, Technical University of Munich, Munich, Germany.
  • Hugo J W L Aerts
    Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
  • Andrei Zhukov
    From the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).
  • Lisa C Adams
    School of Medicine and Health, Department of Diagnostic and Interventional Radiology, Klinikum rechts der Isar, TUM University Hospital, Technical University of Munich, Munich, Germany.